Tue, May 7, 2024
Volume 17, Issue 6 (Nov-Dec 2023)
mljgoums 2023, 17(6): 23-26 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Esmaeili H, Shams Nateri S, Ebrahimi M. The high prevalent involvement of the left coronary artery in Kawasaki disease patients referred to Gorgan's Taleghani Hospital: A retrospective study. mljgoums 2023; 17 (6) :23-26
URL: http://mlj.goums.ac.ir/article-1-1434-en.html
URL: http://mlj.goums.ac.ir/article-1-1434-en.html
1- Congenital Malformations Research Center, Department of Pediatrics, Taleghani Medical Education Center, Golestan University of Medical Sciences, Gorgan, Iran
2- Children's Research Center, Golestan University of Medical Sciences, Gorgan, Iran , M1355ebrahimi@gmail.com
2- Children's Research Center, Golestan University of Medical Sciences, Gorgan, Iran , M1355ebrahimi@gmail.com
Abstract: (302 Views)
Background: Kawasaki disease (KD) is a febrile systemic vasculitis that affects children. Further research is required due to the disease's significance, consequences, and increasing prevalence. This study aimed to determine the frequency of coronary artery complications in patients with KD referred to Taleghani Hospital (Gorgan, Iran) from 2007 to 2017.
Methods: Between 2007 and 2017, 108 cases with a definitive diagnosis of KD were studied retrospectively. Data were obtained from medical records and the patients' biographical, clinical, laboratory, radiographic, and echocardiographic data.
Results: A total of 108 patients diagnosed with KD were involved in the study, 21 (19.44%) of whom showed coronary artery-associated complications. There was no significant difference in clinical and laboratory findings and coronary artery involvement between male and female groups (P-value < 0.05). Left coronary artery (LCA) involvement and the pattern of vascular involvement as ectasia and aneurysm were significantly higher in the echocardiography of the studied patients (P-value = 0.0001).
Conclusion: Kawasaki disease-related coronary artery complication is more common in children under the age of 3, particularly males, in Gorgan. The LCA is the most common site of coronary artery complications in KD children. The findings can improve the prognosis of KD patients and their related heart diseases.
Methods: Between 2007 and 2017, 108 cases with a definitive diagnosis of KD were studied retrospectively. Data were obtained from medical records and the patients' biographical, clinical, laboratory, radiographic, and echocardiographic data.
Results: A total of 108 patients diagnosed with KD were involved in the study, 21 (19.44%) of whom showed coronary artery-associated complications. There was no significant difference in clinical and laboratory findings and coronary artery involvement between male and female groups (P-value < 0.05). Left coronary artery (LCA) involvement and the pattern of vascular involvement as ectasia and aneurysm were significantly higher in the echocardiography of the studied patients (P-value = 0.0001).
Conclusion: Kawasaki disease-related coronary artery complication is more common in children under the age of 3, particularly males, in Gorgan. The LCA is the most common site of coronary artery complications in KD children. The findings can improve the prognosis of KD patients and their related heart diseases.
Research Article: Research Article |
Subject:
Biochemistry
Received: 2021/09/21 | Accepted: 2022/08/3 | Published: 2024/02/26 | ePublished: 2024/02/26
Received: 2021/09/21 | Accepted: 2022/08/3 | Published: 2024/02/26 | ePublished: 2024/02/26
References
1. Lim EJ, Aris IM, Choo J, Wong TY, Li LJ. Association between Coronary Artery Measurements and Retinal Microvasculature in Children with New Onset of Kawasaki Disease. Sci Rep. 2019;9(1):16714. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1038/s41598-019-53220-3] [PMID] []
2. Shiari R. Kawasaki disease; A review article. Arch Pediatr Infect Dis. 2013;2(1):154-9. [View at Publisher] [Google Scholar] [DOI] [DOI:10.5812/pedinfect.11628]
3. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1(2):92-100. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/S1473-3099(01)00065-2] [PMID]
4. McCrindle BW, Li JS, Minich LLA, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: Risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1161/CIRCULATIONAHA.107.690875] [PMID]
5. Mammadov G, Liu HH, Chen WX, Fan GZ, Li RX, Liu FF, et al. Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities. Clin Exp Med. 2020;20(1):21-30. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1007/s10238-019-00596-1] [PMID]
6. Yang M, Pei Q, Zhang J, Weng H, Jing F, Yi Q. Association between adropin and coronary artery lesions in children with Kawasaki disease. Eur J Pediatr. 2021;180(7):2253-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1007/s00431-021-03977-5] [PMID]
7. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-Dose Intravenous Gammaglobulin for Kawasaki Disease. Lancet. 1984;2(8411):1055-8. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/S0140-6736(84)91504-6] [PMID]
8. Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613-20. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/S0140-6736(11)61930-2] [PMID]
9. Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, et al. Infliximab for intensification of primary therapy for Kawasaki disease: A phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9930):1731-8. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/S0140-6736(13)62298-9] [PMID]
10. Yılmazer MM, Öner T, Gökalp S, Doksöz Ö, Güven B, Vupa-Çilengiroğlu Ö, et al. Risk factors for persistence of coronary artery abnormalities in Turkish children with Kawasaki disease. Turk J Pediatr. 2015;57(3):248-53. [View at Publisher] [Google Scholar] [PMID]
11. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Increasing incidence of Kawasaki disease in Japan: Nationwide survey. Pediatr Int. 2008;50(3):287-90. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1111/j.1442-200X.2008.02572.x] [PMID]
12. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J. 2006;25(3):245-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1097/01.inf.0000202068.30956.16] [PMID]
13. Ghelani SJ, Kwatra NS, Spurney CF. Can coronary artery involvement in kawasaki disease be predicted? Diagnostics. 2013;3(2):232-43. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.3390/diagnostics3020232] [PMID] []
14. Cheraghali F, Hajimoradloo N, Roshandel G, Meftah M, Azadfar S. Prevalence of Kawasaki Disease in Children Admitted to Taleghani Medical Center in Gorgan, Iran. J Clin Basic Res. 2018;2(4):54-9. [View at Publisher] [Google Scholar] [DOI] [DOI:10.29252/jcbr.2.4.54]
15. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy. 1967;16(3):178-222. [View at Publisher] [Google Scholar] [PMID]
16. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747-71. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1161/01.CIR.0000145143.19711.78] [PMID]
17. Yonesaka S, Takahashi T, Eto S, Sato T, Otani K, Ueda T, et al. Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms. Cardiol Young. 2010;20(6):602-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1017/S1047951109991132] [PMID]
18. Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 Through 2012. Pediatr Infect Dis J. 2016;35(1):7-12. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1097/INF.0000000000000914] [PMID]
19. Saffar MJ, Reshidighader F. Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002. East Mediterr Health J. 2005;11(1-2):28-35. [View at Publisher] [Google Scholar] [PMID]
20. Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turk J Pediatr. 2020;62(1):1-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.24953/turkjped.2020.01.001] [PMID]
21. Manlhiot C, O'Shea S, Bernknopf B, LaBelle M, Chahal N, Dillenburg RF, et al. Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. Can J Cardiol. 2018;34(3):303-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/j.cjca.2017.12.009] [PMID]
22. Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Clin Rheumatol. 2017;36(2):413-9. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1007/s10067-016-3512-6] [PMID]
23. Dominguez SR, Anderson MS, El-Adawy M, Glodé MP. Preventing coronary artery abnormalities: A need for earlier diagnosis and treatment of Kawasaki disease. Pediatr Infect Dis J. 2012;31(12):1217-20. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1097/INF.0b013e318266bcf9] [PMID]
24. Saundankar J, Yim D, Itotoh B, Payne R, Maslin K, Jape G, et al. The epidemiology and clinical features of kawasaki disease in australia. Pediatrics. 2014;133(4):e1009-14. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1542/peds.2013-2936] [PMID]
25. Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, et al. Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience. J Pediatr. 2018;203:408-15. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/j.jpeds.2018.07.090] [PMID]
26. Lue HC, Chen LR, Lin MT, Chang LY, Wang JK, Lee CY, et al. Epidemiological features of Kawasaki disease in Taiwan, 1976-2007: Results of five nationwide questionnaire hospital surveys. Pediatr Neonatol. 2014;55(2):92-6. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1016/j.pedneo.2013.07.010] [PMID]
27. Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014. Pediatr Infect Dis J. 2017;36(5):482-5. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.1097/INF.0000000000001474] [PMID]
28. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: From the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239-45. [View at Publisher] [Google Scholar] [DOI] [PMID] [DOI:10.2188/jea.JE20140089] [PMID] []
29. Akhavan Karbasi S, Golestan M, Roozbeh P. A 10-year study on the prevalence of cardiovascular affliction among Kawasaki patients in Yazd, Iran. Feyz. 2009;13(1):55-8. [View at Publisher] [Google Scholar]
30. Mahmoudzadeh H, Nikibakhsh AA, Gheibi SS, Aghayar Makoui A. A survey on kawasaki disease in imam khomeini hospital, Urmia. Studies in Medical Sciences. 2008;19(3):236-41. [View at Publisher] [Google Scholar]
31. Amirimoghadam Z, Molaee S, Rezazadeh M, Ghaneei Z, Babaei haidar abadi A, Hemati R. Assessment Heart Involvement in Patients With Kawasaki Disease. J Ilam Univ Med Sci. 2013;21(1):129-34. [View at Publisher] [Google Scholar]
32. Rahbarimanesh A, Salamati P, Ghafourian S, Zekavat M. Relationship between ESR, CRP, platelet count and coronary artery disease in Kawasaki disease. Iranian Journal of Pediatrics. 2005;15(2):139-44. [View at Publisher] [Google Scholar]
33. Zhang D, Liu L, Huang X, Tian J. Insights Into Coronary Artery Lesions in Kawasaki Disease. Front Pediatr. 2020;8:493. [View at Publisher] [Google Scholar] [DOI][PMID] [DOI:10.3389/fped.2020.00493] [PMID] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.